11th Nov 2015 09:24
LONDON (Alliance News) - AstraZeneca PLC said that it conducted a global bond market transaction by issuing a total of USD6 billion of notes.
The transaction consists of five tranches: USD0.4 billion of 3-year floating rate notes; USD1.0 billion of 3-year fixed rate notes with a coupon of 1.750%; USD1.6 billion of 5-year fixed rate notes with a coupon of 2.375%; USD2.0 billion of 10-year fixed rate notes with a coupon of 3.375%; and USD1.0 billion of 30-year fixed rate notes with a coupon of 4.375%.
The company said that it will use the proceeds of the issue to fund the previously announced acquisition of ZS Pharma Inc., to repay certain outstanding commercial paper obligations, and for general corporate purposes.
AstraZeneca noted that the bond issuance does not have any material impact to the its financial guidance for 2015.
Copyright RTT News/dpa-AFX
Related Shares:
Astrazeneca